Jenny Daci Yang, MD
Gastroenterology · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 30
- 7 carriers
- Office
- 1
- Since medical school
- 21 years
- Graduated 2005
Offices
1 location · San Jose Gastroenterology, Inc. · 11 clinicians in this group
Looking this up.
Hospitals listed: Santa Clara Valley Medical Center. That is not proof they admit you there this week.
Plans that list them
30 plans · 7 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Yang’s office at (408) 347-9001 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
30 of 30 plans
| Alignment Health Advantage PPO (PPO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Astiva Health C-SNP WOW - NorCal (HMO C-SNP) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Premier Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Astiva Health Savings Plan - NorCal (HMO) | Astiva Health | Listed | Sep 27, 2026 |
| Blue Shield Inspire (HMO) | Blue Shield of California | Listed | Aug 26, 2026 |
| Central Health Classic Care Plan III (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Dual Access Plan (HMO D-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Embrace Care Plan (HMO C-SNP) | Central Health Medicare Plan | Listed, may be out of date | Sep 15, 2025 |
| Central Health Embrace Choice Plan (HMO C-SNP) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Central Health Valor Care Plan (HMO) | Central Health Medicare Plan | Listed | Aug 15, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A119192 · Current
Licensed to practise in California · since 2011 · expires 2027-02-28 · University of Sao Paulo Faculty of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Gastroenterology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Santa Clara Valley Medical CenterSan Jose, CAAcute Care Hospital · Government - Local · Has an emergency department · Birthing-friendlyPart of Santa Clara Valley Health and Hospital System, which runs 3 hospitalsPatients rate it 3 of 5 · 70% would definitely recommend itOverall rating: 2 of 5 starsWorse than the national rate — SSI - Colon Surgery: 2.572, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.563, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.256, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.369, Oct 2024 – Sep 2025
See every measure and the patient survey for Santa Clara Valley Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 1 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| SSI - Colon SurgeryInfections | 2.572 | Worse | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.563 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.256 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.369 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.25 (0.3 to 2.2) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.07 (0.76 to 1.38) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 214.59 (167.38 to 261.8) · 108 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.8 · 41 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6 · 141 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 124 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.3 · 501 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 653 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 348 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 4,502 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.24 (0.04 to 0.43) · 9,014 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,216 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.54 (2.51 to 6.58) · 1,421 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.54 (0 to 3.2) · 288 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,446 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.61 (4.09 to 19.14) · 294 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.29 (3.39 to 11.2) · 299 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.36) · 333 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.23 (0 to 0.78) · 7,538 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 94 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.735 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 2.573 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.6 · 185 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.1 · 951 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 56.3 · 128 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 6.4 · 644 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 1.3 · 699 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 921 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.9 to 8.1) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.6 (9.4 to 16.5) · 226 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 94 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.4 · 54 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 242 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.9 to 17.4) · 702 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.4) · 195 cases | No different | Jan 2024 – Dec 2024 |
What patients said (4,032 patients answered, 29% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 2 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 73% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 82% |
| Yes, staff "did" give patients information about help after discharge | 82% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 67% |
| Staff "always" explained new medications | 71% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 69% |
| Nurses "always" treated them with courtesy and respect | 80% |
| "Always" quiet at night | 43% |
| "YES", patients would definitely recommend the hospital | 70% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 83% |
Original Medicare doctor bills
$76,165
Medicare paid this office $76,165 for 274 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | $19,035 | $219 |
| Pathology examination of tissue using a microscope, intermediate complexity | 136 | $10,262 | $40 |
| New patient visit (30+ min) | 91 | $7,552 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $6,231 | $82 |
| Return visit (30+ min) | 44 | $5,795 | $111 |
See all 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 87 | $19,035 | $219 |
| Pathology examination of tissue using a microscope, intermediate complexity | 136 | $10,262 | $40 |
| New patient visit (30+ min) | 91 | $7,552 | $83 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 76 | $6,231 | $82 |
| Return visit (30+ min) | 44 | $5,795 | $111 |
| Short return visit (20+ min) | 61 | $5,561 | $78 |
| Special stained specimen slides to identify organisms including interpretation and report | 23 | $3,279 | $96 |
| Biopsy of large bowel using a flexible endoscope | 50 | $3,189 | $64 |
| New patient visit (45+ min) | 20 | $2,369 | $118 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,659 | $138 |
| Ultrasound scan of organ tissue for measuring elasticity | 11 | $1,188 | $108 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 52 | $250 | $5 |
Procedures Medicare counted
| Colonoscopy | 174 | More than 91% of doctors who do this |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 62 | More than 67% of doctors who do this |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 108 | 65 | 89 | 87 | 74 | 76 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 83 | 59 | 66 | 100 | 86 | 87 |
| Biopsy of large bowel using a flexible endoscope | 119 | 49 | 40 | 70 | 59 | 50 |
| Diagnostic exam of large bowel using a flexible endoscope | – | – | 29 | 22 | 16 | 12 |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
274 Original Medicare patients in 2024. Average age 74 · Women 69% · Also on Medicaid 69% · Health risk score 1.30. At or below the middle of the specialty; the typical gastroenterology clinician is at 1.42.
Conditions among them: High blood pressure 75% · Diabetes 45% · Chronic kidney disease 24% · Coronary heart disease 22% · Heart failure 14% · Atrial fibrillation 13% · Cancer 12% · COPD 12% · Depression 12% · Dementia 9% · Stroke 5%.
The office billed $425,490, Medicare allowed $102,510 and paid $76,165; for 892 services of 37 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 274 | 892 | 74 | 1.30 | $425,490 | $76,165 |
| 2023 | 330 | 1,029 | 75 | 1.37 | $325,410 | $89,113 |
| 2022 | 382 | 1,291 | 75 | 1.45 | $407,177 | $116,707 |
| 2021 | 343 | 902 | 75 | 1.53 | $330,896 | $89,294 |
| 2020 | 289 | 667 | 74 | 1.84 | $247,994 | $65,477 |
| 2019 | 412 | 1,072 | 73 | 1.41 | $275,784 | $98,194 |
| 2018 | 420 | 1,132 | 74 | 1.69 | $276,691 | $100,715 |
| 2017 | 415 | 1,494 | 74 | 1.61 | $397,405 | $125,263 |
| 2016 | 330 | 1,226 | 73 | 1.62 | $400,960 | $117,571 |
| 2015 | 326 | 1,159 | 74 | 1.57 | $352,910 | $103,987 |
| 2014 | 410 | 1,648 | 72 | 1.28 | $424,908 | $138,885 |
| 2013 | 343 | 1,644 | 73 | 1.62 | $340,007 | $155,256 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 84 | $18,895 | $220 |
| Pathology examination of tissue using a microscope, intermediate complexity | 142 | $11,832 | $38 |
| Return visit (30+ min) | 69 | $9,958 | $120 |
| New patient visit (30+ min) | 84 | $8,231 | $98 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 74 | $6,683 | $90 |
| New patient visit (45+ min) | 42 | $6,355 | $151 |
| Short return visit (20+ min) | 57 | $5,617 | $80 |
| Biopsy of large bowel using a flexible endoscope | 59 | $4,392 | $74 |
| Special stained specimen slides to identify organisms including interpretation and report | 21 | $2,889 | $96 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 14 | $2,188 | $156 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $2,103 | $117 |
| Diagnostic exam of large bowel using a flexible endoscope | 16 | $2,102 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,426 | $71 |
| New patient visit (15+ min) | 11 | $665 | $60 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 66 | $297 | $4 |
2022: 18 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 98 | $22,623 | $226 |
| Return visit (30+ min) | 75 | $11,802 | $119 |
| New patient visit (45+ min) | 79 | $11,753 | $149 |
| Pathology examination of tissue using a microscope, intermediate complexity | 153 | $11,195 | $37 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 41 | $7,533 | $179 |
| New patient visit (30+ min) | 78 | $7,445 | $95 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 86 | $7,305 | $84 |
| Biopsy of large bowel using a flexible endoscope | 69 | $6,124 | $87 |
| Short return visit (20+ min) | 56 | $5,072 | $82 |
| Special stained specimen slides to identify organisms including interpretation and report | 35 | $4,510 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $3,741 | $65 |
| Diagnostic exam of large bowel using a flexible endoscope | 22 | $3,514 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,869 | $93 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,315 | $122 |
| Complete ultrasound scan of abdomen | 18 | $2,260 | $98 |
| New patient visit (15+ min) | 12 | $496 | $41 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 104 | $496 | $5 |
| Measurement of liver stiffness | 11 | $290 | $26 |
2021: 13 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 66 | $15,430 | $234 |
| New patient visit (30+ min) | 137 | $14,156 | $103 |
| Return visit (30+ min) | 60 | $9,074 | $121 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $8,691 | $98 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,225 | $183 |
| Biopsy of large bowel using a flexible endoscope | 40 | $5,897 | $147 |
| Short return visit (20+ min) | 57 | $5,885 | $83 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,730 | $66 |
| Diagnostic exam of large bowel using a flexible endoscope | 29 | $4,342 | $150 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,464 | $124 |
| Pathology examination of tissue using a microscope, intermediate complexity | 34 | $2,565 | $37 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,889 | $94 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 108 | $533 | $5 |
2020: 12 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 59 | $13,998 | $237 |
| New patient visit (30+ min) | 93 | $7,987 | $86 |
| Return visit (30+ min) | 60 | $6,883 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 34 | $6,752 | $188 |
| Short return visit (20+ min) | 76 | $5,939 | $65 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 63 | $5,824 | $90 |
| Biopsy of large bowel using a flexible endoscope | 49 | $3,485 | $71 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,753 | $67 |
| New patient visit (45+ min) | 11 | $1,744 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 14 | $1,556 | $97 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 11 | $1,391 | $126 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 70 | $343 | $5 |
2019: 11 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 83 | $19,502 | $235 |
| New patient visit (30+ min) | 195 | $15,616 | $80 |
| Return visit (30+ min) | 102 | $13,611 | $93 |
| Biopsy of large bowel using a flexible endoscope | 119 | $12,334 | $104 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 105 | $9,520 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,645 | $182 |
| Short return visit (20+ min) | 62 | $4,619 | $65 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 25 | $3,070 | $123 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 14 | $917 | $65 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 174 | $860 | $5 |
| Measurement of liver stiffness | 15 | $596 | $37 |
2018: 15 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 65 | $15,318 | $232 |
| Return visit (30+ min) | 117 | $15,128 | $88 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 65 | $11,825 | $182 |
| New patient visit (30+ min) | 145 | $11,510 | $79 |
| Biopsy of large bowel using a flexible endoscope | 91 | $10,248 | $113 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 87 | $7,856 | $88 |
| Short return visit (20+ min) | 56 | $4,041 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $4,033 | $122 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 37 | $2,942 | $65 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 12 | $2,552 | $213 |
| New patient visit (45+ min) | 17 | $2,183 | $128 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 17 | $1,711 | $101 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 162 | $709 | $4 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 68 | $706 | $10 |
| Measurement of liver stiffness | 16 | $563 | $35 |
2017: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 62 | $14,208 | $229 |
| Biopsy of large bowel using a flexible endoscope | 112 | $12,293 | $110 |
| Pathology examination of tissue using a microscope, intermediate complexity | 91 | $11,913 | $66 |
| Short return visit (20+ min) | 135 | $11,862 | $66 |
| New patient visit (30+ min) | 128 | $11,713 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 62 | $11,421 | $178 |
| Return visit (30+ min) | 60 | $8,923 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 89 | $8,480 | $94 |
| New patient visit (45+ min) | 32 | $4,802 | $150 |
| Special stained specimen slides to identify organisms including interpretation and report | 40 | $4,727 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $4,020 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 32 | $2,526 | $65 |
| Diagnostic exam of large bowel using a flexible endoscope | 12 | $1,877 | $156 |
| Diagnostic exam of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 12 | $1,310 | $101 |
| Use of a drug to induce depression of consciousness by physician performing a procedure, each additional 15 minutes | 85 | $1,048 | $11 |
| New patient visit (15+ min) | 13 | $854 | $66 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 66 | $687 | $10 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monito | 118 | $566 | $5 |
| New patient visit (10+ min) | 15 | $549 | $37 |
2016: 16 services
| Pathology examination of tissue using a microscope, intermediate complexity | 152 | $25,147 | $72 |
| Biopsy of large bowel using a flexible endoscope | 120 | $14,299 | $119 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 56 | $13,224 | $236 |
| Short return visit (20+ min) | 128 | $11,183 | $68 |
| New patient visit (30+ min) | 98 | $9,667 | $99 |
| Special stained specimen slides to identify organisms including interpretation and report | 56 | $7,793 | $100 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 65 | $6,473 | $97 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 20 | $3,785 | $180 |
| New patient visit (45+ min) | 22 | $3,208 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $2,407 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 21 | $1,865 | $64 |
| Return visit (30+ min) | 13 | $1,484 | $93 |
| Special stained specimen slides to examine tissue including interpretation and report | 16 | $1,343 | $71 |
| Microscopic genetic analysis of tumor, manual | 11 | $1,318 | $120 |
| New patient visit (15+ min) | 19 | $1,270 | $67 |
| New patient visit (10+ min) | 22 | $876 | $40 |
2015: 17 services
| Pathology examination of tissue using a microscope, intermediate complexity | 116 | $16,714 | $53 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 58 | $15,661 | $265 |
| Biopsy of large bowel using a flexible endoscope | 100 | $13,578 | $134 |
| New patient visit (30+ min) | 105 | $10,205 | $97 |
| Short return visit (20+ min) | 104 | $9,853 | $61 |
| Special stained specimen slides to identify organisms including interpretation and report | 40 | $5,496 | $86 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 53 | $5,285 | $98 |
| New patient visit (45+ min) | 32 | $4,565 | $143 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 21 | $3,903 | $177 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $2,741 | $64 |
| Special stained specimen slides to examine tissue including interpretation and report | 25 | $2,330 | $60 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 15 | $1,803 | $120 |
| Return visit (30+ min) | 12 | $1,274 | $85 |
| New patient visit (15+ min) | 16 | $1,118 | $70 |
| Limited ultrasound scan of abdomen | 11 | $1,095 | $91 |
| New patient visit (10+ min) | 23 | $812 | $35 |
| Injection beneath lining of large bowel using a flexible endoscope | 11 | $280 | $25 |
2014: 18 services
| Biopsy of large bowel using a flexible endoscope | 129 | $18,908 | $147 |
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 69 | $17,749 | $257 |
| New patient visit (30+ min) | 183 | $17,023 | $93 |
| Pathology examination of tissue using a microscope, intermediate complexity | 176 | $13,772 | $33 |
| Short return visit (20+ min) | 135 | $13,136 | $66 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 78 | $8,164 | $100 |
| Special stained specimen slides to identify organisms including interpretation and report | 65 | $5,862 | $67 |
| Special stained specimen slides to examine tissue including interpretation and report | 65 | $5,615 | $53 |
| New patient visit (45+ min) | 36 | $5,236 | $145 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 41 | $4,804 | $64 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,597 | $180 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,251 | $232 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,921 | $122 |
| Complete ultrasound scan of abdomen | 18 | $2,579 | $143 |
| Return visit (30+ min) | 18 | $1,836 | $97 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,386 | $92 |
| New patient visit (10+ min) | 34 | $1,116 | $33 |
| New patient visit (15+ min) | 11 | $769 | $70 |
2013: 19 services
| Removal of polyps or growths of large bowel using an endoscope with mechanical snare | 76 | $20,989 | $273 |
| Biopsy of large bowel using a flexible endoscope | 121 | $18,266 | $149 |
| New patient visit (45+ min) | 94 | $14,121 | $150 |
| Pathology examination of tissue using a microscope, intermediate complexity | 150 | $13,840 | $35 |
| New patient visit (30+ min) | 116 | $11,464 | $99 |
| Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | 84 | $8,516 | $100 |
| Short return visit (20+ min) | 89 | $8,456 | $68 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 46 | $8,238 | $175 |
| Special stained specimen slides to examine tissue including interpretation and report | 69 | $7,199 | $59 |
| Special stained specimen slides to identify organisms including interpretation and report | 66 | $6,238 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $5,669 | $62 |
| Return visit (30+ min) | 45 | $5,483 | $100 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 28 | $3,969 | $90 |
| Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 14 | $3,262 | $233 |
| Diagnostic exam of large bowel using a flexible endoscope | 11 | $1,696 | $154 |
| Complete ultrasound scan of abdomen | 12 | $1,672 | $139 |
| New patient visit (10+ min) | 20 | $758 | $38 |
| Injection beneath lining of large bowel using a flexible endoscope | 23 | $607 | $26 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $537 | $34 |
Medicaid work
$1,601 in 2024
Medicaid paid $1,601 for 252 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| TISSUE EXAM BY PATHOLOGIST | 140 | $812 |
| COLONOSCOPY W/LESION REMOVAL | 56 | $765 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 31 | $24 |
| New patient visit (30+ min) | 25 | $0 |
| 2024 | 252 | 4 | 21 | $1,601 |
| 2023 | 617 | 9 | 27 | $5,607 |
| 2022 | 1,036 | 11 | 37 | $6,338 |
| 2021 | 1,177 | 10 | 47 | $3,250 |
| 2020 | 387 | 7 | 34 | $976 |
| 2019 | 1,296 | 8 | 47 | $9,207 |
| 2018 | 880 | 9 | 40 | $5,577 |
See the largest Medicaid services in earlier years
2023
| COLONOSCOPY W/LESION REMOVAL | 67 | $2,084 |
| TISSUE EXAM BY PATHOLOGIST | 186 | $1,733 |
| Upper gastrointestinal endoscopy with biopsy | 67 | $859 |
| COLONOSCOPY AND BIOPSY | 43 | $374 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 110 | $209 |
| Return visit (30+ min) | 105 | $172 |
| New patient visit (30+ min) | 13 | $150 |
| Short return visit (20+ min) | 13 | $26 |
| New patient visit (45+ min) | 13 | $0 |
2022
| COLONOSCOPY W/LESION REMOVAL | 115 | $2,262 |
| Upper gastrointestinal endoscopy with biopsy | 149 | $1,950 |
| COLONOSCOPY AND BIOPSY | 65 | $602 |
| 1ST HOSP IP/OBS HIGH 75 | 19 | $418 |
| Return visit (30+ min) | 157 | $327 |
| New patient visit (45+ min) | 12 | $277 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 234 | $244 |
| TISSUE EXAM BY PATHOLOGIST | 238 | $183 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 16 | $76 |
| New patient visit (30+ min) | 19 | $0 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 12 | $0 |
2021
| Upper gastrointestinal endoscopy with biopsy | 175 | $1,519 |
| COLONOSCOPY W/LESION REMOVAL | 66 | $621 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 27 | $473 |
| New patient visit (30+ min) | 334 | $216 |
| Return visit (30+ min) | 113 | $199 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 265 | $109 |
| Short return visit (20+ min) | 74 | $60 |
| COLONOSCOPY AND BIOPSY | 14 | $44 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 57 | $10 |
| TISSUE EXAM BY PATHOLOGIST | 52 | $0 |
2020
| New patient visit (30+ min) | 240 | $558 |
| Return visit (30+ min) | 31 | $272 |
| Upper gastrointestinal endoscopy with biopsy | 13 | $65 |
| COLONOSCOPY AND BIOPSY | 12 | $38 |
| Short return visit (20+ min) | 27 | $26 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 50 | $15 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 14 | $1 |
2019
| COLONOSCOPY W/LESION REMOVAL | 108 | $2,784 |
| Upper gastrointestinal endoscopy with biopsy | 147 | $2,269 |
| COLONOSCOPY AND BIOPSY | 107 | $1,709 |
| New patient visit (30+ min) | 349 | $1,374 |
| Return visit (30+ min) | 299 | $564 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 159 | $479 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 112 | $28 |
| Short return visit (20+ min) | 15 | $0 |
2018
| Upper gastrointestinal endoscopy with biopsy | 115 | $2,219 |
| COLONOSCOPY AND BIOPSY | 90 | $1,667 |
| New patient visit (30+ min) | 253 | $661 |
| Return visit (30+ min) | 211 | $413 |
| COLONOSCOPY W/LESION REMOVAL | 14 | $331 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing a gastrointestinal endoscopic service that sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intra-service time; patient age 5 years or older (additional time may be reported with 99153, as appropriate) | 59 | $211 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; initial 15 minutes of intraservice time, patient age 5 years or older | 109 | $72 |
| Moderate sedation services provided by the same physician or other qualified health care professional performing the diagnostic or therapeutic service that the sedation supports, requiring the presence of an independent trained observer to assist in the monitoring of the patient's level of consciousness and physiological status; each additional 15 minutes intraservice time (List separately in addition to code for primary service) | 16 | $2 |
| Short return visit (20+ min) | 13 | $0 |
Drugs they prescribed that Part D paid
$292,337
Pharmacies billed $292,337 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 1,048) in 2024. At or below the middle of the specialty; the typical gastroenterology clinician is at 0%.
744 generic and 304 brand-name prescriptions · $292,337 in drug cost · 29 antibiotic prescriptions to 16 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Vemlidy | 140 | $207,759 | $1,484 |
| Linzess | 26 | $14,184 | $546 |
| Sod Sulf-Potass Sulf-Mag Sulf | 75 | $5,236 | $70 |
| Gavilyte-G | 198 | $2,866 | $14 |
| Entecavir | 36 | $2,677 | $74 |
See all 15 drugs
| Vemlidy | 140 | $207,759 | $1,484 |
| Linzess | 26 | $14,184 | $546 |
| Sod Sulf-Potass Sulf-Mag Sulf | 75 | $5,236 | $70 |
| Gavilyte-G | 198 | $2,866 | $14 |
| Entecavir | 36 | $2,677 | $74 |
| Mesalamine | 11 | $2,098 | $191 |
| Peg-3350 and Electrolytes | 75 | $1,169 | $16 |
| Pantoprazole | 102 | $988 | $10 |
| Omeprazole | 68 | $582 | $9 |
| Peg 3350-Electrolyte | 15 | $341 | $23 |
| Gavilyte-C | 16 | $315 | $20 |
| Lansoprazole | 13 | $267 | $21 |
| Dicyclomine | 22 | $260 | $12 |
| Famotidine | 49 | $258 | $5 |
| Metoclopramide | 11 | $81 | $7 |
Year by year
| 2024 | 1,048 | 514 | 0% (0) | 29% | $292,337 |
| 2023 | 1,073 | 465 | 0% (0) | 33% | $315,243 |
| 2022 | 1,107 | 499 | 0% (0) | None | $395,897 |
| 2021 | 1,100 | 504 | 0% (0) | None | $307,287 |
| 2020 | 900 | 363 | 0% (0) | 39% | $417,887 |
| 2019 | 1,030 | 495 | 0% (0) | 38% | $387,998 |
| 2018 | 892 | 371 | 0% (0) | 38% | $379,401 |
| 2017 | 923 | 415 | 0% (0) | 37% | $561,185 |
| 2016 | 703 | 342 | 0% (0) | 41% | $795,374 |
| 2015 | 700 | 281 | 0% (0) | 41% | $430,413 |
| 2014 | 641 | 299 | None | 42% | $711,698 |
| 2013 | 431 | 218 | None | 41% | $30,797 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 13 drugs
| Vemlidy | 162 | $235,409 | $1,453 |
| Linzess | 39 | $22,376 | $574 |
| Entecavir | 21 | $5,374 | $256 |
| Sod Sulf-Potass Sulf-Mag Sulf | 66 | $5,088 | $77 |
| Suprep | 36 | $3,854 | $107 |
| Gavilyte-G | 163 | $2,969 | $18 |
| Omeprazole | 113 | $2,270 | $20 |
| Pantoprazole | 104 | $1,856 | $18 |
| Famotidine | 46 | $846 | $18 |
| Peg 3350-Electrolyte | 32 | $831 | $26 |
| Dicyclomine | 29 | $696 | $24 |
| Peg-3350 and Electrolytes | 24 | $537 | $22 |
| Gavilyte-C | 16 | $319 | $20 |
2022: 18 drugs
| Vemlidy | 170 | $233,406 | $1,373 |
| Linzess | 24 | $15,414 | $642 |
| Suprep | 132 | $14,475 | $110 |
| Creon | 11 | $5,378 | $489 |
| Sod Sulf-Potass Sulf-Mag Sulf | 35 | $2,789 | $80 |
| Omeprazole | 109 | $1,480 | $14 |
| Pantoprazole | 109 | $1,000 | $9 |
| Gavilyte-G | 68 | $903 | $13 |
| Peg 3350-Electrolyte | 37 | $710 | $19 |
| Peg-3350 and Electrolytes | 45 | $630 | $14 |
| Dicyclomine | 27 | $478 | $18 |
| Famotidine | 46 | $402 | $9 |
| Tenofovir Disoproxil | 12 | $350 | $29 |
| Gavilyte-C | 20 | $337 | $17 |
| Spironolactone | 18 | $199 | $11 |
| Levofloxacin | 18 | $161 | $9 |
| Amoxicillin | 17 | $146 | $9 |
| Furosemide | 18 | $81 | $5 |
2021: 17 drugs
| Vemlidy | 168 | $204,892 | $1,220 |
| Linzess | 54 | $26,785 | $496 |
| Suprep | 163 | $17,256 | $106 |
| Dexilant | 18 | $9,442 | $525 |
| Clenpiq | 11 | $1,687 | $153 |
| Tenofovir Disoproxil | 16 | $1,634 | $102 |
| Pantoprazole | 122 | $1,555 | $13 |
| Peg 3350-Electrolyte | 87 | $1,539 | $18 |
| Omeprazole | 133 | $1,066 | $8 |
| Peg-3350 and Electrolytes | 42 | $481 | $11 |
| Famotidine | 30 | $479 | $16 |
| Gavilyte-G | 33 | $465 | $14 |
| Lansoprazole | 18 | $363 | $20 |
| Dicyclomine | 18 | $349 | $19 |
| Gavilyte-C | 22 | $314 | $14 |
| Amoxicillin | 16 | $199 | $12 |
| Levofloxacin | 13 | $176 | $14 |
2020: 17 drugs
| Vemlidy | 183 | $214,919 | $1,174 |
| Linzess | 35 | $19,013 | $543 |
| Dexilant | 24 | $11,036 | $460 |
| Entecavir | 43 | $2,767 | $64 |
| Suprep | 18 | $1,796 | $100 |
| Gavilyte-G | 102 | $1,416 | $14 |
| Pantoprazole | 78 | $957 | $12 |
| Tenofovir Disoproxil | 12 | $720 | $60 |
| Omeprazole | 114 | $658 | $6 |
| Peg 3350-Electrolyte | 33 | $533 | $16 |
| Peg-3350 and Electrolytes | 41 | $486 | $12 |
| Esomeprazole Magnesium | 12 | $389 | $32 |
| Famotidine | 17 | $384 | $23 |
| Azathioprine | 12 | $260 | $22 |
| Gavilyte-N | 13 | $210 | $16 |
| Amoxicillin | 22 | $184 | $8 |
| Levofloxacin | 21 | $178 | $8 |
2019: 14 drugs
| Vemlidy | 176 | $197,087 | $1,120 |
| Linzess | 49 | $24,348 | $497 |
| Entecavir | 52 | $12,827 | $247 |
| Gavilyte-G | 234 | $3,360 | $14 |
| Suprep | 12 | $1,182 | $98 |
| Peg-3350 and Electrolytes | 80 | $993 | $12 |
| Omeprazole | 127 | $966 | $8 |
| Dicyclomine | 27 | $587 | $22 |
| Pantoprazole | 41 | $521 | $13 |
| Gavilyte-N | 22 | $424 | $19 |
| Peg 3350-Electrolyte | 18 | $288 | $16 |
| Ranitidine | 31 | $228 | $7 |
| Amoxicillin | 12 | $149 | $12 |
| Levofloxacin | 12 | $107 | $9 |
2018: 18 drugs
| Vemlidy | 89 | $96,968 | $1,090 |
| Xifaxan | 11 | $22,823 | $2,075 |
| Entecavir | 61 | $20,244 | $332 |
| Hepsera | 13 | $17,866 | $1,374 |
| Linzess | 31 | $16,929 | $546 |
| Tenofovir Disoproxil | 25 | $8,022 | $321 |
| Cholestyramine | 12 | $1,775 | $148 |
| Peg 3350-Electrolyte | 81 | $1,554 | $19 |
| Gavilyte-N | 64 | $1,306 | $20 |
| Omeprazole | 89 | $752 | $8 |
| Gavilyte-G | 51 | $708 | $14 |
| Peg-3350 and Electrolytes | 53 | $653 | $12 |
| Dicyclomine | 40 | $545 | $14 |
| Pantoprazole | 42 | $519 | $12 |
| Mercaptopurine | 13 | $427 | $33 |
| Levofloxacin | 20 | $314 | $16 |
| Ranitidine | 34 | $239 | $7 |
| Amoxicillin | 20 | $201 | $10 |
2017: 19 drugs
| Epclusa | 11 | $281,201 | $25,564 |
| Viread | 56 | $59,136 | $1,056 |
| Xifaxan | 14 | $29,233 | $2,088 |
| Vemlidy | 25 | $25,021 | $1,001 |
| Entecavir | 55 | $22,821 | $415 |
| Hepsera | 12 | $15,489 | $1,291 |
| Lialda | 13 | $8,620 | $663 |
| Linzess | 12 | $4,249 | $354 |
| Peg 3350-Electrolyte | 90 | $1,564 | $17 |
| Gavilyte-N | 62 | $1,145 | $18 |
| Suprep | 13 | $1,106 | $85 |
| Gavilyte-G | 69 | $915 | $13 |
| Pantoprazole | 103 | $877 | $9 |
| Omeprazole | 106 | $694 | $7 |
| Peg-3350 and Electrolytes | 55 | $675 | $12 |
| Propranolol | 14 | $324 | $23 |
| Spironolactone | 26 | $311 | $12 |
| Ranitidine | 42 | $259 | $6 |
| Dicyclomine | 16 | $117 | $7 |
2016: 16 drugs
| Harvoni | 13 | $415,164 | $31,936 |
| Viread | 52 | $52,408 | $1,008 |
| Entecavir | 23 | $21,835 | $949 |
| Linzess | 26 | $8,359 | $322 |
| Lialda | 11 | $6,226 | $566 |
| Peg 3350-Electrolyte | 103 | $1,834 | $18 |
| Gavilyte-N | 76 | $1,485 | $20 |
| Moviprep | 13 | $1,143 | $88 |
| Pantoprazole | 51 | $548 | $11 |
| Omeprazole | 70 | $540 | $8 |
| Peg-3350 and Electrolytes | 35 | $443 | $13 |
| Doxycycline Hyclate | 11 | $430 | $39 |
| Propranolol | 17 | $372 | $22 |
| Trilyte With Flavor Packets | 14 | $261 | $19 |
| Ranitidine | 39 | $261 | $7 |
| Metronidazole | 17 | $247 | $15 |
2015: 18 drugs
| Viread | 32 | $30,333 | $948 |
| Linzess | 43 | $12,937 | $301 |
| Lialda | 17 | $11,431 | $672 |
| Adefovir Dipivoxil | 13 | $11,040 | $849 |
| Entecavir | 11 | $10,992 | $999 |
| Dexilant | 19 | $4,744 | $250 |
| Peg 3350-Electrolyte | 79 | $1,601 | $20 |
| Pantoprazole | 65 | $795 | $12 |
| Omeprazole | 93 | $789 | $8 |
| Gavilyte-N | 40 | $763 | $19 |
| Peg-3350 and Electrolytes | 31 | $439 | $14 |
| Ranitidine | 53 | $369 | $7 |
| Loperamide | 12 | $332 | $28 |
| Gavilyte-G | 19 | $289 | $15 |
| Trilyte With Flavor Packets | 12 | $219 | $18 |
| Levofloxacin | 13 | $169 | $13 |
| Dicyclomine | 12 | $87 | $7 |
| Amoxicillin | 11 | $68 | $6 |
2014: 13 drugs
| Sovaldi | 21 | $588,365 | $28,017 |
| Linzess | 28 | $6,981 | $249 |
| Amitiza | 12 | $3,600 | $300 |
| Peg-3350 | 106 | $2,149 | $20 |
| Omeprazole | 122 | $1,197 | $10 |
| Gavilyte-N | 49 | $990 | $20 |
| Pantoprazole | 45 | $555 | $12 |
| Peg-3350 and Electrolytes | 21 | $299 | $14 |
| Ondansetron | 16 | $292 | $18 |
| Trilyte With Flavor Packets | 12 | $233 | $19 |
| Ranitidine | 29 | $183 | $6 |
| Levofloxacin | 15 | $175 | $12 |
| Amoxicillin | 17 | $132 | $8 |
2013: 10 drugs
| Nexium | 19 | $5,324 | $280 |
| Clarithromycin | 22 | $2,012 | $91 |
| Peg-3350 With Flavor Packs | 84 | $1,753 | $21 |
| Omeprazole | 74 | $859 | $12 |
| Pantoprazole | 27 | $706 | $26 |
| Gavilyte-N | 34 | $679 | $20 |
| Trilyte With Flavor Packets | 19 | $363 | $19 |
| Ranitidine | 11 | $346 | $31 |
| Amoxicillin | 24 | $247 | $10 |
| Peg-3350 and Electrolytes | 14 | $204 | $15 |
Money from drug and device companies
$410 in 2025
| 2025 | 6 | 10 | None | $410 |
| 2024 | 4 | 7 | None | $142 |
| 2023 | 2 | 14 | None | $289 |
| 2022 | 3 | 8 | None | $250 |
| 2021 | 5 | 24 | $2,100 | $2,620 |
| 2020 | 4 | 20 | $2,480 | $2,953 |
| 2019 | 5 | 33 | $2,600 | $3,685 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| 3-D Matrix | None | $235 | 1 payment
|
| Abbvie | Linzess | $94 | 4 payments
|
| Janssen Biotech | Tremfya | $22 | 1 payment
|
| Braintree Laboratories | Suflave | $21 | 1 payment
|
| Pfizer | Velsipity | $19 | 1 payment
|
| Madrigal Pharmaceuticals | Rezdiffra | $19 | 1 payment
|
See all 9 published payments
| 3-D Matrix | Meals · 2025-12-10 | None | $235 |
| Abbvie | Meals · 2025-10-16 | Creon | $20 |
| Janssen Biotech | Meals · 2025-10-01 | Tremfya | $22 |
| Braintree Laboratories | Meals · 2025-09-03 | Suflave | $21 |
| Abbvie | Meals · 2025-08-08 | Linzess | $20 |
| Abbvie | Meals · 2025-05-23 | Rinvoq | $33 |
| Abbvie | Meals · 2025-05-08 | Linzess | $20 |
| Madrigal Pharmaceuticals | Meals · 2025-04-10 | Rezdiffra | $19 |
| Pfizer | Meals · 2025-01-15 | Velsipity | $19 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $142
| Abbvie | Mavyret | $57 | 3 payments
|
| Gilead Sciences | None | $49 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $20 | 1 payment
|
| Braintree Laboratories | Sutab | $17 | 1 payment
|
2023: $289
| Gilead Sciences | None | $203 | 10 payments
|
| AbbVie | Mavyret | $86 | 4 payments
|
2022: $250
| Gilead Sciences | Vemlidy | $194 | 5 payments
|
| Abbvie | Mavyret | $44 | 2 payments
|
| Edwards Lifesciences | None | $12 | 1 payment
|
2021: $2,620
| Gilead Sciences | Vemlidy | $2,239 | 9 payments
|
| AbbVie | Mavyret | $232 | 10 payments
|
| Braintree Laboratories | Sutab | $94 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $41 | 2 payments
|
| Merck Sharp & Dohme | Dificid | $14 | 1 payment
|
2020: $2,953
| Gilead Sciences | None | $2,728 | 9 payments
|
| AbbVie | Mavyret | $171 | 9 payments
|
| Nestle HealthCare Nutrition | Zenpep | $31 | 1 payment
|
| Alfasigma USA | None | $23 | 1 payment
|
2019: $3,685
| Gilead Sciences | Vemlidy | $3,447 | 21 payments
|
| Shionogi | Mulpleta | $106 | 5 payments
|
| AbbVie | Humira | $92 | 5 payments
|
| Takeda Pharmaceuticals U.S.A. | Entyvio | $21 | 1 payment
|
| Braintree Laboratories | Suprep Bowel Prep | $19 | 1 payment
|
Checkups this office reported
6 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 100.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Age Appropriate Screening ColonoscopyAs Medicare defines this measure | 0% | 688 |
| Appropriate Follow-Up Interval for Normal Colonoscopy in Average Risk PatientsAs Medicare defines this measure | 100% | 62 |
| Colon cancer screeningEligible adults who got a colon cancer test | 100%That's most of the people this applied to. | 860 |
| Colonoscopy Interval for Patients with a History of Adenomatous Polyps - Avoidance of Inappropriate UseAs Medicare defines this measure | 100% | 97 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 1,271 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 100%That's most of the people this applied to. | 1,109 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Improved the patient portal
- Offers telehealth visits
Professional record
- NPI
- 1700021987
- Licence
- CA A119192California A119192: Current · expires 2027-02-28
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RG0100X (207RG0100X)
- Mailing address
- 2331 Montpelier Dr Ste B, San Jose, CA, 95116
- NPI first listed
- 2008-12-02
- NPI last updated
- 2023-11-07
- NPI record certified
- 2023-11-07
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 200 Jose Figueres Ave Ste 265, San Jose, CA, 95116 · 231 Oconnor Dr, San Jose, CA, 95128